SCHEMBL13303878

SCHEMBL13303878

B[C@]1(C)OC(C)[C@@H](O)[C@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14182229 0.77 — —
SCHEMBL22454044 0.72 — —
SCHEMBL4460537 0.72 — —
SCHEMBL4460539 0.72 — —
SCHEMBL3238830 0.72 — —
SCHEMBL18722723 0.72 — —
SCHEMBL18805883 0.70 — —
SCHEMBL24974883 0.70 FUCA1 (0.32) —
SCHEMBL13010055 0.70 PYGB (0.36) —
SCHEMBL21539187 0.70 PYGB (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100158866-A1 PREDICTION OF HCV TREATMENT RESPONSE ROCHE PALO ALTO LLC 2010-06-24 — — US disclosed
Send feedback